文献速递系统性红斑狼疮

系统性红斑狼疮诊断时预测最终发展为狼疮肾炎的因素

Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus.
PubMed 文献 · Semin Arthritis Rheum · 2018-02-23

研究纳入278例新诊断且无肾脏表现的系统性红斑狼疮患者,随访比较基线特征,分析未来发展为狼疮肾炎的预测因素。多因素分析显示年龄、C3、抗dsDNA滴度和抗Sm抗体为预测因素,低白蛋白球蛋白比值(AGR)与风险增高关联最强(aHR 4.972)。

要点

  • 诊断时低AGR与未来狼疮肾炎风险增高关联最强(aHR 4.972)。
  • 年轻、低C3、高抗dsDNA滴度及抗Sm抗体阳性亦为预测因素。
  • 研究为随访278例新诊断无肾脏表现SLE患者的观察性分析。

核心结论

  • 诊断SLE时年轻、低C3、高抗dsDNA滴度及抗Sm抗体阳性与未来狼疮肾炎风险相关,但低AGR值时风险最大,提示免疫球蛋白相对总蛋白比例较高与肾炎发生相关。

研究设计与样本

  • 随访278例新诊断且无肾脏表现的系统性红斑狼疮患者,比较最终发展为狼疮肾炎者与未发展者的基线特征,AGR按白蛋白/(总蛋白-白蛋白)计算,采用Cox比例风险模型识别预测因素。

主要发现

  • 278例患者中241例未发展为狼疮肾炎,37例在随访期间发展为狼疮肾炎。
  • 单因素分析中,年轻、低C3、低C4、高抗dsDNA滴度、抗Sm抗体、抗RNP抗体及低AGR与狼疮肾炎风险增高相关。
  • 多因素分析中,年龄aHR 0.928(95%CI 0.895-0.961,p<0.001)、C3 aHR 0.977(95%CI 0.966-0.989,p<0.001)、抗dsDNA滴度aHR 1.004(95%CI 1.000-1.007,p=0.026)、抗Sm抗体aHR 2.097(95%CI 1.040-4.229,p=0.038)为预测因素。
  • 低AGR与未来狼疮肾炎风险增高关联最强,aHR 4.972(95%CI 2.394-10.326,p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate factors predictive of future lupus nephritis development when systemic lupus erythematosus (SLE) is diagnosed. METHODS: Patients with newly diagnosed SLE without renal manifestations were followed for development of lupus nephritis, comparing findings at baseline between those who did or did not develop nephritis. Albumin-to-globulin ratio (AGR) was calculated as albumin/(total protein-albumin). Cox proportional hazard model was used to identify predictors of lupus nephritis. RESULTS: Of 278 patients, 241 did not and 37 did develop lupus nephritis during follow-up. On univariate analysis, young age, low C3, low C4, high anti-dsDNA titre, anti-Sm antibody, anti-RNP antibody and low AGR were associated with a higher risk of lupus nephritis. On multivariate analysis, factors predictive of nephritis were age [adjusted hazard ratio (aHR) 0.928, 95% confidence interval (CI): 0.895-0.961, p < 0.001], C3 (aHR 0.977, 95% CI: 0.966-0.989, p < 0.001), anti-dsDNA titre (aHR 1.004, 95% CI: 1.000-1.007, p = 0.026) and anti-Sm antibody (aHR 2.097, 95% CI: 1.040-4.229, p = 0.038). In particular, a low AGR (aHR 4.972, 95% CI: 2.394-10.326, p < 0.001) was strongly associated with an increased risk of future lupus nephritis development. CONCLUSION: Young age, low C3, high anti-dsDNA titre and presence of anti-Sm antibody at diagnosis of SLE were associated with a risk of future lupus nephritis, but the hazard was greatest with a low AGR value, suggesting that a greater proportion of immunoglobulin relative to total protein is associated with the development of nephritis.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Kwon OC, Lee JS, Ghang B, et al. Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus. Semin Arthritis Rheum. 2018. PMID: 29566965. doi:10.1016/j.semarthrit.2018.02.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。